Updated October 22, 2026
DEA registration has become an important consideration for state-licensed medical cannabis businesses. A federal rule effective April 28, 2026, placed qualifying medical marijuana in Schedule III and created a registration pathway for state-licensed medical marijuana manufacturers, distributors, and dispensers.
The change does not authorize recreational cannabis operations or automatically grant federal registration to every state license holder. Businesses must evaluate their license, activities, application status, and continuing compliance obligations.
For operators considering DEA registration, the most immediate questions are whether they qualify, which application applies, and what happens while an application is pending.
What Changed Under the Federal Medical Marijuana Rule?
The April 2026 rule moved marijuana in FDA-approved products or subject to a state medical marijuana license into Schedule III. It also established a registration framework that recognizes existing state medical marijuana licensing systems.
This medical marijuana framework should not be confused with the separate proceeding addressing broader marijuana rescheduling. A registration issued under the medical framework does not authorize nonmedical cannabis activities. Read the published federal rule.
State authorization and federal registration remain different. A state medical marijuana license establishes permission under state law, but it does not automatically establish that the business holds the federal registration required for its activities.
Which Cannabis Businesses Can Apply?
The medical marijuana registration framework covers qualifying state-licensed businesses seeking registration as:
- Manufacturers, including businesses engaged in authorized cultivation, production, processing, packaging, and labeling.
- Distributors, which receive and transfer medical marijuana within the authorized supply chain.
- Dispensers, which provide medical marijuana to individuals authorized under state law.
A vertically integrated business may need more than one registration category. Its federal registration cannot exceed the activities authorized by its state medical marijuana license.
An adult-use license alone does not qualify a business for this medical marijuana pathway. Businesses operating in both markets should identify precisely which activities and products fall within their medical authorization. See the registration categories and limitations in § 1301.13(k).
Can Businesses Still Apply After the Initial Filing Window?
Yes. The initial filing window has closed, but it was not a permanent deadline for submitting a registration application.
The rule provided special treatment for applications submitted within 60 days of publication. It directed DEA to make every effort to process those applications within six months and permitted qualifying early applicants to conduct specified medical marijuana activities under their state licenses while their applications remained pending.
California’s Department of Cannabis Control reports that DEA continues accepting applications, but applications submitted after June 26, 2026, are outside that initial expedition provision. See the regulator’s federal rescheduling update.
Businesses applying now should not assume that filing an application alone authorizes operations while review is pending. Likewise, the six-month language is not a guaranteed approval deadline.
Operators that applied during the initial window should retain their submission confirmation, filing date, application materials, and supporting state licenses.
How Does the DEA Registration Process Work?
1. Confirm the Applicant and Its State Authorization
Identify the legal entity seeking registration, the activities it conducts, and the state medical marijuana license supporting those activities.
As a practical preparation step, compare the application against the company’s formation documents, license records, operating locations, and actual business activities. Resolve inconsistencies before filing.
2. Use the Correct DEA Application
DEA’s current registration page lists Form 224M for medical marijuana dispensaries and Form 225 for categories that include manufacturers, distributors, and analytical laboratories.
Applicants should use the current online process and instructions for their specific activity. Requirements can differ by registration category. Access DEA’s registration instructions and application links.
Depending on the application and follow-up requests, preparation may include reviewing:
- Business identity, addresses, and tax identification information.
- Current state licenses and authorized activities.
- Relevant ownership, management, and background information.
- Products and controlled substances the business handles.
- Operating procedures, records, and security arrangements.
- Prior regulatory actions and information responsive to application questions.
This is a preparation checklist, not a statement that every applicant must submit the same documents. The applicable form and DEA’s requests control what must be provided.
4. Address DEA Review and Ongoing Compliance
A state license is conclusive evidence of state authorization for the relevant activity. It does not eliminate DEA’s public-interest review or applicable treaty requirements.
Businesses should plan for follow-up questions and maintain the records needed to support their application and continued operations. See the federal registration standard.
How Much Does DEA Rely on State Compliance?
The medical marijuana rule gives substantial recognition to state regulatory systems.
For registrants under this framework, the rule:
- Treats compliance with state physical-security requirements as sufficient.
- Requires acceptance of state reports, records, and forms to the maximum extent permissible.
- Permits state-compliant disposal.
- Recognizes state labeling, packaging, and sealing requirements, subject to an applicable federal warning requirement.
Businesses should therefore avoid assuming they must replace every existing procedure with a separate federal system. The appropriate approach is to determine what their state-compliant systems already satisfy and identify any remaining federal obligations. See § 1301.13(k)(4), (8), (9), and (10).
Manufacturers also face specific requirements. The rule establishes a nominal-price DEA purchase-and-resale mechanism for marijuana crops, includes an administrative fee, and requires DEA access to specified storage facilities pending completion of that transaction. Manufacturer registrations must also identify permitted cultivation areas.
These provisions deserve separate review when planning cultivation or manufacturing operations. See § 1301.13(k)(6).
What Happens if the State License Expires or Is Suspended?
Maintaining the underlying state medical marijuana license is essential.
Under the rule, suspension, revocation, or expiration of that license automatically suspends the associated DEA registration. State renewal deadlines and enforcement matters therefore have direct federal consequences. See § 1301.13(k)(3).
How Does Rescheduling Affect Section 280E?
Section 280E generally disallows deductions and credits for businesses trafficking in Schedule I or II controlled substances where the activity is prohibited by federal or state law. Read 26 U.S.C. § 280E.
Moving qualifying medical marijuana to Schedule III changes that analysis. Treasury has explained that rescheduling generally removes the Section 280E barrier for activities that no longer involve Schedule I or II substances.
However, the transition requires care. Treasury announced plans for guidance addressing mixed business activities and a potential full-taxable-year transition rule. That announcement described expected guidance, not a completed determination of every operator’s tax treatment. Read Treasury’s announcement.
The September 29, 2026, Treasury/IRS Priority Guidance Plan continues to identify Section 280E guidance as a project without establishing a completion deadline. Read the current guidance plan.
Businesses should coordinate with their tax advisers before changing deductions, allocating expenses between medical and adult-use activities, or filing amended returns. Neither filing a DEA application nor receiving a registration automatically resolves prior-year tax liability.
What Should Businesses With Medical and Adult-Use Operations Do?
Federal medical marijuana registration does not extend to adult-use activities.
For mixed operators, we recommend reviewing how licenses, inventory systems, sales records, contracts, and accounting distinguish the two sides of the business. The appropriate operational separation depends on applicable law, license conditions, and the company’s activities.
The April rule should not be described as imposing a universal requirement that every mixed operator maintain separate facilities and bank accounts. Specific separation requirements should be identified and evaluated rather than assumed. Review the medical-only scope of the rule.
Preparing Your Cannabis Business for DEA Registration
Before applying or responding to DEA, consider the following practical steps:
- Confirm that the applicant holds the necessary state medical marijuana authorization.
- Identify the registration categories that match its actual activities.
- Review any earlier application and preserve evidence of its submission date.
- Reconcile application information with licenses and company records.
- Assess existing compliance procedures against the specific federal requirements.
- Coordinate tax decisions with a qualified tax adviser.
- Establish responsibility for renewals, agency correspondence, and changes in license status.
Brown & Blaier, PC works with cannabis businesses on legal and business issues affecting their operations. If your company is evaluating DEA registration, reviewing its structure, or preparing for a transaction, contact our firm to discuss your business and the scope of assistance needed.
This article is for informational purposes only and does not constitute legal advice. The DEA registration framework is subject to ongoing agency guidance. Businesses should consult experienced counsel before taking action.